NDC 0078-0729

Betoptic S

Betaxolol Hydrochloride

Betoptic S is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Betaxolol Hydrochloride.

Product ID0078-0729_905ba189-456c-4aa4-8231-39a971374ad8
NDC0078-0729
Product TypeHuman Prescription Drug
Proprietary NameBetoptic S
Generic NameBetaxolol Hydrochloride
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date1996-01-15
Marketing CategoryNDA /
Application NumberNDA019845
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameBETAXOLOL HYDROCHLORIDE
Active Ingredient Strength3 mg/mL
Pharm ClassesAdrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0078-0729-10

1 BOTTLE in 1 CARTON (0078-0729-10) > 10 mL in 1 BOTTLE
Marketing Start Date2022-08-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Betoptic S" or generic name "Betaxolol Hydrochloride"

NDCBrand NameGeneric Name
0065-0246Betoptic Sbetaxolol hydrochloride
0078-0729Betoptic Sbetaxolol hydrochloride
17478-705BetaxololBetaxolol Hydrochloride
10702-013BETAXOLOL HYDROCHLORIDEbetaxolol hydrochloride
10702-014BETAXOLOL HYDROCHLORIDEbetaxolol hydrochloride
61314-245Betaxolol HydrochlorideBetaxolol Hydrochloride

Trademark Results [Betoptic S]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BETOPTIC S
BETOPTIC S
75359301 2248882 Live/Registered
Novartis AG
1997-09-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.